Navigation Links
Active surveillance for low-risk prostate cancer may offer better quality-of-life
Date:11/30/2010

gnosed patients with certain prostate-specific antigen measurements, digital rectal examinations, and biopsies, with treatment at disease progression or patient choice). Probabilities were derived from previous studies and literature review.

The researchers found that in men 65 years old, active surveillance, with IMRT for progression, was the most effective strategy (defined as the strategy associated with the highest quality-adjusted life expectancy [QALE], producing 11.07 quality-adjusted life-years [QALYs; a higher QALY reflects a year of life in a preferred health state]). "Brachytherapy and IMRT were less effective at 10.57 and 10.51 QALYs, respectively. Radical prostatectomy was the least effective treatment, yielding 10.23 QALYs. The difference between the most and least effective initial treatment was 0.34 QALYs, or 4.1 months of QALE. In contrast, active surveillance provided 6.0 additional months of QALE compared with brachytherapy, the most effective initial treatment," the authors write.

The researchers also conducted an analysis to identify how much greater the risk of prostate cancer-specific death would have to be under active surveillance compared with initial treatment for the 2 approaches to be associated with equal QALE. "For QALE to be equal, 15 percent of men undergoing active surveillance would have to die of prostate cancer as opposed to 9 percent who received initial treatment, a lifetime relative risk of death of 0.6 for initial treatment vs. surveillance."

The authors note that the QALE gains and the optimal strategy were highly dependent on individual preferences for living under active surveillance and for having been treated.

"The quality-of-life advantage associated with active surveillance is robust in this model of treatment alternatives for men with clinically localized, low-risk prostate cancer. This benefit reflects the deferred and substantially lower incidence of adverse effects of treatment
'/>"/>

Contact: Teresa Herbert
teresa_herbert@dfci.harvard.edu
617-632-5653
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Embark Health Selects the Jellyvision Lab's Interactive Conversation Technology to Educate Website Visitors on Advance Directives
2. Abington Memorial Hospital's Travelers Clinic Can Protect Travelers From The Now Active Yellow Fever
3. Lumension Unveils Intelligent Application Whitelisting that Operationalizes a Proactive Endpoint Security Approach
4. New Ankle Arthritis Treatments Help Boomers Stay Active
5. Antibodies linked to cardiovascular disease increase in patients with active lupus
6. WellNet Supports HPM Institute Director in Calling for More Active Enterprise Involvement in Managing Healthcare Quality and Costs
7. LodgeNet Interactive Names Frank P. Elsenbast As Next Chief Financial Officer
8. Tahitian Noni Bioactive Beverages™ Contain Iridoids
9. Iridoids in Tahitian Noni Bioactive Beverages™ are Found to be Extremely Stable
10. Five New Tahitian Noni Bioactive Beverages™ Announced
11. Commonwealth Leverage Group and Helium Interactive Form HIE Go-To-Market Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... San Francisco, California (PRWEB) July 30, 2014 ... reach USD 46.05 billion by 2020, according to a ... for minimally invasive procedures and the growing prevalence of ... market growth over the forecast period. In addition, the ... the rising market penetration of minimally invasive procedures in ...
(Date:7/30/2014)... Building ENT and Allergy Associates (ENTA) into ... in Westchester County takes the best of everything. Leading ... corporate structure and protocols, and a staff that is ... Chief Financial Officer to help run it. According to ... it possesses. In fact, in the WCBJ’s July 21st, ...
(Date:7/30/2014)... 30, 2014 All the children at ... abandonment, rejection, abuse and exploitation tend to mar their ... hopelessness and dejection. Quality youth development has underpinnings in ... support boosts confidence and in the foreseeable future, would ... this light that the mere presence of Foundation members ...
(Date:7/30/2014)... HealthDay Reporter , TUESDAY, July 29, ... set the stage for harmful health habits, including eating disorders, ... from 1982 to 2012 also found a link between early ... a woman was when she started her first diet, the ... behaviors -- like vomiting or laxative misuse," said study researcher ...
(Date:7/30/2014)... Dennis Thompson HealthDay Reporter ... nutrients in fruits and vegetables are vital to good health ... Once you,ve hit five servings of fruits and vegetables each ... new research review suggests. The human body may only ... and vegetables every day, limiting its ability to absorb important ...
Breaking Medicine News(10 mins):Health News:Global Catheters Market - Industry Size, Trends, Analysis, Growth, Players, Outlook and Forecast Research Report from 2014 to 2020: Grand View Research, Inc 2Health News:Global Catheters Market - Industry Size, Trends, Analysis, Growth, Players, Outlook and Forecast Research Report from 2014 to 2020: Grand View Research, Inc 3Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 2Health News:The Leading Ear, Nose, and Throat Practice in Westchester County Has One of the Leading CFO’s in Westchester County! 3Health News:The Edusei Foundation Donates Food and Assorted Items to the Fathers’ Home Care Ministries in Takoradi, Ghana 2Health News:Dieting at Young Age Often Backfires, Study Says 2Health News:Dieting at Young Age Often Backfires, Study Says 3Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 3
... at the 5th Annual Games for Health Conference ... Project, organizers of the 5th Annual Games for Health ... by SharpBrains, a leading market research company focused on ... Cognitive Health track builds upon previous year,s sampling of ...
... benefit Christopher & Dana Reeve FoundationSHORT HILLS, N.J., May ... will be held Monday, June 22nd at 8:00 ... New York. Directed by Marcia Milgrom Dodge, currently directing ... Larry Yurman ("Grey Gardens"), Born for Broadway ...
... experts say consequence can be severe , , MONDAY, May 18 ... the health-care industry as it tries to serve the poor, ... 10 poor women recovering from breast cancer do not ... , Those who do not follow instructions to take these ...
... LEHIGH VALLEY, Pa., May 18 Air Products (NYSE: ... three of its U.S. healthcare businesses to Landauer-Metropolitan, Inc. ... and infusion services in the northeast, based in Mount ... disclosed.The sale includes Air Products, ownership interests in certain ...
... Associate,s Degrees to Earn Their Master,s SALT LAKE CITY, May ... www.wgu.edu , has launched two new master,s degree programs ... the RN to MSN in Nursing Leadership and Management. The ... registered nurses who have an associate,s degree or diploma in ...
... education come fewer chronic problems, study finds , , MONDAY, May ... appear to have a better chance of living a longer ... Social Research Council, who analyzed data from 2002 to 2007, ... were richer and better educated were less likely to have ...
Cached Medicine News:Health News:Games for Health Conference Announces First Cognitive Health Track Powered by SharpBrains 2Health News:Games for Health Conference Announces First Cognitive Health Track Powered by SharpBrains 3Health News:Games for Health Conference Announces First Cognitive Health Track Powered by SharpBrains 4Health News:Tickets Now on Sale for Born for Broadway 2Health News:Poor Women Seem to Be Skipping Breast Cancer Drugs 2Health News:Air Products Sells Three U.S. Healthcare Businesses to Landauer-Metropolitan 2Health News:Western Governors University Offers Two New Master's Degrees in Nursing 2Health News:Western Governors University Offers Two New Master's Degrees in Nursing 3Health News:Money May Matter, Health-Wise, in Old Age 2
(Date:7/29/2014)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life ... total revenues of $39.8 million for the second quarter ... of $24.5 million for the second quarter of 2013. ... sold on May 30, 2014, has been accounted for ... been excluded from continuing operations for all periods. ...
(Date:7/29/2014)...  EnteroMedics Inc. (NASDAQ: ETRM ), the ... obesity, metabolic diseases and other gastrointestinal disorders, today announced ... August 7, 2014 at 11:00 AM Eastern Time to ... 30, 2014 and to provide a business update. ... conference call may be accessed by dialing (877) 280-7473 ...
(Date:7/29/2014)... 2014  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... specific pathogens that cause serious infections and diseases, announced ... in the Company,s stock, the NYSE MKT (the "Exchange") ... practice. The Company stated that its policy is not ... Synthetic Biologics, Inc. Synthetic Biologics, Inc. (NYSE ...
Breaking Medicine Technology:Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 2Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 3Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 4Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 5Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 6Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 7Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 8Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 9Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 10Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 11Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 12Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 13Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 14Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 15Sequenom, Inc. Reports Financial Results For The Second Quarter Of 2014 16EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 2EnteroMedics to Host Second Quarter 2014 Financial Results and Business Update Conference Call 3Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2
... diagnosisTAMPA, Fla., May 14 Moffitt Cancer ... have signed a license agreement on phospholipid ... been granted exclusive worldwide rights to Moffitt,s interests in ... maintenance fees, and royalties on sales. Moffitt and Frantz ...
... indicate statistically significant improvement in ACR20 responses over ... MEDX ) today announced that the ... active rheumatoid arthritis (RA) receiving methotrexate successfully met ... recently completed 70-patient multi-center, randomized, double-blind, placebo-controlled Phase ...
Cached Medicine Technology:Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC 2Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 2Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 3Medarex Announces Primary Endpoint Achieved in MDX-1100 Anti-IP-10 Antibody Phase 2 Trial for Rheumatoid Arthritis 4
... is the #1 Pipettor for sub-microliter ... and reliability. Continuously adjustable. Features lPLUS, ... Easy interchangeable ejector buttons to fit ... rapid pipet tip ejector with three ...
... The Finnpipette Digital offers improved ergonomics ... rounded handle, modified grippy finger rest ... operator comfort and efficiency. Finnpipette Digitals ... power-boosted gearing mechanism (pat. pend.) and ...
... Pipettor is the #1 Pipettor for ... comfort, and reliability. Continuously adjustable. Features ... sub-micrometer. Easy interchangeable ejector buttons to ... Adjustable rapid pipet tip ejector with ...
... Recommended for aqueous samples of moderate viscosity and density. Proven ergonomic ... greasing. Volume Range(ul) ... 0.8~1.5 Imprecision(%) ... Precision (ul) ...
Medicine Products: